May 18, 2023 / 06:00PM GMT
Robert Blum - Lytham Partners, LLC - Analyst
All right. Hello, everyone. Thank you all for joining us for the Lytham Partners Spring 2023 Investor Conference. My name is Robert Blum, Managing Partner of Lytham Partners.
Up next, we have a panel presentation, which we hope you'll find insightful, with executives from three different companies that are looking to advance innovations in health care. Each of them with ongoing or planned Phase 3 trials here. We've titled the panel Phase 3 drugs to watch.
Let's not waste a time, jump right in. If we could start off with everyone introducing themselves, providing a bit of background on both themselves and the company. Lax, why don't we begin with you?
Lax Bhat - Reviva Pharmaceuticals Holdings, Inc. - Founder, President & CEO
Sure, Robert. Thanks for having me here again. It's a wonderful opportunity for Reviva to present here at Lytham Conference. My name is Lax Bhat, I'm Founder and CEO of Reviva Pharmaceuticals. My background, I'm a scientist by training. Been in the industry for a little over
Reviva Pharmaceuticals Holdings, Inc. at Lytham Partners Spring Investor Conference (Virtual) Panel Transcript
May 18, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers